Loading insider details...
Beta
Latest Form 4 (Sep 4, 2026): Grant/Award of 320,000 PLX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 4, 2026 | Protalix BioTherapeutics, Inc. (PLX) | Grant/Award | 320,000 | n/a |
| Dec 23, 2025 | Protalix BioTherapeutics, Inc. (PLX) | Purchase | 56,000 | $101.4K |
| Sep 4, 2025 | Protalix BioTherapeutics, Inc. (PLX) | Grant/Award | 195,000 | n/a |
| Apr 3, 2024 | Protalix BioTherapeutics, Inc. (PLX) | Grant/Award | 263,960 | n/a |
| Oct 20, 2023 | Protalix BioTherapeutics, Inc. (PLX) | Purchase | 48,387 | $67.7K |
| Aug 17, 2023 | Protalix BioTherapeutics, Inc. (PLX) | Grant/Award | 800,000 | n/a |
| Sep 9, 2022 | Protalix BioTherapeutics, Inc. (PLX) | Grant/Award | 750,000 | n/a |
| Apr 13, 2022 | Protalix BioTherapeutics, Inc. (PLX) | Purchase | 68,000 | $102.0K |
| Feb 28, 2022 | Protalix BioTherapeutics, Inc. (PLX) | Grant/Award | 637,531 | n/a |
| Aug 13, 2020 | Protalix BioTherapeutics, Inc. (PLX) | Grant/Award | 447,927 | n/a |